The objective of CD-MEDICS is to obtain an instrument that will be a low-cost non-invasive intelligent diagnosis system at point of care that could bring benefits to patients and healthcare professionals.

The specific objectives of CD-MEDICS are:

• demonstration of usefulness of anti-glutenin antibodies in the screening and diagnosis of coeliac disease
• demonstration of usefulness of anti-glutenin antibodies in the development of immunoassays as well as HLA typing protocols
• development of a generic genosensor array micromodules for HLA typing
• development of individual micromodules for sample treatment, mixing, metering, nucleic acid amplification, HLA typing and autoantibody detection
• development of a nanostructured microsystem with multiple sample treatment modules integrated with the sensor arrays on a single disposable device.
• provision of a wireless communication approach that seamlessly links devices through one of many potential methods
• clinical evaluation encompassing both end-user feedback and bioethical issues
• innovation management ensuring exploitation of developed technology
• integration of multidisciplinary education and skills development with research activities
• ethical scrutiny and fostering of dialogue as a means of contributing to our well-being of advanced technology as well as to enthusiasm for science